Results 131 to 140 of about 6,775 (167)

Real-World Selection of Venetoclax-Obinutuzumab Versus BTK Inhibitor Therapy for Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. [PDF]

Eur J Haematol
Tidswell R, Owen C, Shafey M, Perry S, Cox-Kennett N, Sterrett R, Peters A, Puckrin R.   +7 more
europepmc   +1 more source

Association between the incidence of infusion-related reactions by obinutuzumab and the dose of corticosteroid as premedication: a multicenter retrospective cohort study. [PDF]

J Pharm Health Care Sci
Ohtsubo T, Yamamoto K, Matumoto S, Ito K, Sasa Y, Tomishima K, Dote S, Makihara K, Wakasugi Y, Mitsuie T, Yamagiwa K, Sato K, Hasegawa H, Uoshima N, Kitahiro Y, Tomogane K.   +15 more
europepmc   +1 more source

Fixed-duration VenO vs FCR/BR in fit patients with untreated CLL: primary analysis of the phase 3 CRISTALLO trial.

Blood
Sharman JP, Laurenti L, Ferrant E, Casado Montero LF, Mulligan SP, Harrup R, Opat S, Ibatici A, Marasca R, Sportoletti P, Thadani-Mulero M, Cazares O, Huang W, Jiang Y, Clark E, Jin HY, Boyer M, Morschhauser F.   +17 more
europepmc   +1 more source

Advancing Care in Lupus Nephritis: Expert Perspectives on Current Practices and Future Directions in Italy. [PDF]

J Clin Med
Doria A, Franceschini F, Gesualdo L, Moroni G, Mosca M, Sinico RA, Roccatello D.   +6 more
europepmc   +1 more source

Case Report: Anti-glomerular basement membrane disease during pregnancy with favorable renal outcome, sequential biopsies, and dual anti-α1/α3(IV) and anti-LM521 antibodies. [PDF]

Front Immunol
Zhuang J, Gu S, Qu Y, Zhang C, Kuang H, Cui Z, Tian X, Jiang H.   +7 more
europepmc   +1 more source

A novel anti-CD20, concabody, enhances immunotherapy efficacy by targeting MPZL1 and augmenting antibody-induced cell death. [PDF]

Front Oncol
Choi AY, Kim D, Lee C, Ahn JS, Yang DH, Lee D, Kim JY.   +6 more
europepmc   +1 more source

Successful use of obinutuzumab in focal segmental glomerulosclerosis with inadequate response to rituximab: a case report. [PDF]

Front Nephrol
Henriques AR, Venda J, Ferreira E, Oliveira N, Sá H.   +4 more
europepmc   +1 more source

Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. [PDF]

Clin Exp Med
D'Amato M, Rapolla CM, Benedetti E, Bocchia M, Capochiani E, Carlomagno G, Ciofini S, Giachetti R, Maestrini G, Moretti S, Nasso D, Papini G, Pirrotta MT, Simonetti F, Santini S, Vannucchi A, Galimberti S, Sanna A.   +17 more
europepmc   +1 more source